**Core Concept**
Meningococcal meningitis is a severe infection caused by Neisseria meningitidis, requiring prompt antibiotic treatment to prevent complications and mortality. The empirical drug of choice should be effective against the most common serogroups responsible for outbreaks.

**Why the Correct Answer is Right**
Ceftriaxone, a third-generation cephalosporin, is the empirical drug of choice for treating meningococcal meningitis. It has excellent penetration into cerebrospinal fluid (CSF) and broad-spectrum activity against Neisseria meningitidis, including serogroups A, B, C, W, and Y. Ceftriaxone's effectiveness is due to its ability to inhibit cell-wall synthesis in bacteria, leading to bacterial lysis and death.

**Why Each Wrong Option is Incorrect**
**Option A:** Penicillin is not the empirical drug of choice due to increasing resistance among Neisseria meningitidis isolates, particularly in serogroup B. While still effective against some strains, penicillin is not the preferred option for initial treatment.
**Option B:** Vancomycin has limited CSF penetration and is not the first-line treatment for meningococcal meningitis. It may be used in combination with other antibiotics for resistant or complicated cases.
**Option D:** Rifampin is an antibiotic used for prophylaxis in close contacts of patients with meningococcal meningitis, but it is not the empirical drug of choice for treating the infection itself.

**Clinical Pearl / High-Yield Fact**
Ceftriaxone is often administered in combination with vancomycin for suspected cases of meningococcal meningitis in regions with high prevalence of penicillin-resistant Neisseria meningitidis.

**Correct Answer:** C. Ceftriaxone